-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-2007_executive.pdf
January 01, 2007 - Layout 1
Background
Rheumatoid and psoriatic arthritis are
among the most disabling forms of
arthritis. Rheumatoid arthritis (RA), which
affects 1 percent of the U.S. adult
population (or upwards of 2 million
individuals), is an autoimmune disease that
involves inflammation of the synovium (a
thin layer of tissue lin…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/deprescribing-protocol.pdf
July 01, 2023 - drug events (ADEs), increased healthcare utilization (e.g., emergency department visits,
acute care … drug
events, adverse drug withdrawal
events, mortality)
Implementation measures
(e.g., barriers … Adverse drug events in ambulatory care. … Clarifying adverse drug events: a clinician's guide to
terminology, documentation, and reporting. … Reducing Adverse Drug Events in Older Adults.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-adults_research-protocol.pdf
December 01, 2010 - National Library of
Medicine’s TOXLINE® database and the MedEffectTM Canada Adverse Drug Reaction
Database
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-218-osteoporosis-disposition-comments.pdf
April 23, 2019 - Statements about the risk of potential adverse drug
reactions are made without the rigor that is applied … Esophageal cancer is
not a class specific adverse drug reaction for either
bisphosphonates or denosumab … increased fracture risk) and hypothetical benefits
(reduced risk of AFFs, ONJ and other potential adverse … drug reactions) of discontinuing treatment with a
bisphosphonate after 3 to 5 years (i.e., taking
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_executive.pdf
June 01, 2011 - Layout 1
Background
Almost 75 million American adults—
approximately one-third—have
hypertension. The prevalence of
hypertension increases with advancing age
such that more than half of people 55 to 74
years old and approximately three-fourths
of those age 75 years and older are
affected. In addition to being the pr…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
September 01, 2011 - Layout 1
Background
Juvenile idiopathic arthritis (JIA) is the
most common rheumatologic disease in
childhood, with an overall prevalence of 7
to 400 per 100,000 children. JIA is an
important cause of chronic disease in
childhood, with prevalence similar to type I
diabetes mellitus. Several classification
systems ha…
-
effectivehealthcare.ahrq.gov/sites/default/files/thromboembolism-update-executive-170622.pdf
June 01, 2017 - Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update
Comparative Effectiveness Review
Number 191
Venous Thromboembolism Prophylaxis in
Major Orthopedic Surgery: Systematic
Review Update
Executive Summary
Introduction
Major orthopedic surgery carries a high
risk for venous …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/thromboembolism-update-executive-170622.pdf
June 01, 2017 - Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update
Comparative Effectiveness Review
Number 191
Venous Thromboembolism Prophylaxis in
Major Orthopedic Surgery: Systematic
Review Update
Executive Summary
Introduction
Major orthopedic surgery carries a high
risk for venous …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/headaches-pregnancy.pdf
March 23, 2019 - OR “Tetracyclic antidepressant” OR
mirtazapine OR “Somatostatin analog” OR octreotide)
AND
("drug-related … side effects and adverse reactions"[MESH] OR “abnormalities, drug-
induced”[MESH] OR birth defect OR
-
effectivehealthcare.ahrq.gov/products/headaches-pregnancy/protocol
November 12, 2019 - lithium OR “Tetracyclic antidepressant” OR mirtazapine OR “Somatostatin analog” OR octreotide)
AND
("drug-related … side effects and adverse reactions"[MESH] OR “abnormalities, drug-induced”[MESH] OR birth defect OR
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-239-acute-migraine-evidence-summary.pdf
December 01, 2020 - Evidence Summary for CER 239: Acute Treatments for Episodic Migraine
Comparative Effectiveness Review
Number 239
Acute Treatments for Episodic Migraine
Evidence Summary
Main Points
• Compared with placebo, treatments such as triptans, NSAIDs (nonsteroidal anti-
inflammatory drugs), dihydroergotamine, antieme…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-response-deprescribing.pdf
February 01, 2024 - drug event; ADWE = adverse drug withdrawal event; CI = confidence interval; ED = emergency
department … Adverse
drug events in ambulatory care. … Clarifying
adverse drug events: a clinician's guide to
terminology, documentation, and reporting. … Reducing Adverse Drug Events in Older
Adults. … Drug Events in
Older Adults.
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-215-depression-older-adults-comments.pdf
March 28, 2019 - CER 215 Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Adverse Effects of Pharmacologic Treatments of Major Depression
in Older Adults
Draft review available for public comment fr…
-
effectivehealthcare.ahrq.gov/products/atypical-antipsychotics-off-label-update/research-protocol
May 19, 2010 - Current Page Topic Timeline May. 19, 2010 Research Protocol Jun. 1, 2011 Topic Suggestion Sep. 27, 2011 Systematic Review Jan. 12, 2012 Disposition of Comments Report Jul. 5, 2016 Surveillance Report Efficacy and Comparative Effectiveness of Off-Label Use of Atypical Antipsychotics – Update
Research Protocol Archi…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_surveillance.pdf
March 01, 2013 - Psoriatic Arthritis Surveillance Assesment_CER 54_Low
CER #54:
Drug Therapy for Psoriatic Arthritis in Adults:
Update of a 2007 Report
Original release date:
June 2012
Surveillance Report:
March 2013
Key Findings:
- Key Question 1: Conclusion regarding biologic Disease-
Modifying Antirheumatic D…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-update_research-protocol.pdf
May 07, 2010 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: May 07, 2010
Evidence-based Practice Center Systematic Review Protocol
Project Title: Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors (ACEIs)
…
-
effectivehealthcare.ahrq.gov/products/dietary-supplements/research
April 30, 2012 - Current Page Topic Timeline Apr. 1, 2009 Topic Suggestion Dec. 21, 2010 Research Protocol Apr. 30, 2012 Systematic Review Jul. 3, 2013 Surveillance Report Dietary Supplements in Adults Taking Cardiovascular Drugs
Systematic Review Archived April 30, 2012 Web Version [NLM Site] Download Main Document PDF 6.8 MB
…
-
effectivehealthcare.ahrq.gov/products/treatments-acute-pain/research
December 29, 2020 - Treatments for Acute Pain: A Systematic Review
Systematic Review December 29, 2020 Download Main Document PDF 3.3 MB
Related Files Download Evidence Summary [PDF · 298.3 KB] Download Appendix E [XLSX · 151.1 KB] Download Appendix F [XLSX · 28.2 KB] Download Disposition of Comments Report [PDF · 1.2 MB…
-
effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-summary.pdf
April 01, 2020 - Nonopioid Pharmacologic Treatments for Chronic Pain: Evidence Summary
Purpose of Review
Evaluate the benefits and harms of nonopioid drugs
in randomized controlled trials of patients with spe-
cific types of chronic pain, considering the effects on
pain, function, quality of life, and adverse events.
Key Messages…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/schizophrenia-adult_research-protocol.pdf
September 23, 2016 - Treatments for Adults with Schizophrenia: A Systematic Review
Source: www.effectivehealthcare.ahrq.gov
Published online: September 23, 2016
Evidence-based Practice Center Systematic Review Protocol
Project Title: Treatments for Adults with Schizophrenia: A Systematic Review
Initial publication date: August …